1. Home
  2. CRIS vs SURG Comparison

CRIS vs SURG Comparison

Compare CRIS & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • SURG
  • Stock Information
  • Founded
  • CRIS 2000
  • SURG 2006
  • Country
  • CRIS United States
  • SURG United States
  • Employees
  • CRIS N/A
  • SURG N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • SURG Advertising
  • Sector
  • CRIS Health Care
  • SURG Consumer Discretionary
  • Exchange
  • CRIS Nasdaq
  • SURG Nasdaq
  • Market Cap
  • CRIS 32.8M
  • SURG 31.3M
  • IPO Year
  • CRIS 2000
  • SURG N/A
  • Fundamental
  • Price
  • CRIS $3.16
  • SURG $1.45
  • Analyst Decision
  • CRIS Strong Buy
  • SURG Buy
  • Analyst Count
  • CRIS 3
  • SURG 2
  • Target Price
  • CRIS $23.00
  • SURG $8.50
  • AVG Volume (30 Days)
  • CRIS 32.8K
  • SURG 125.6K
  • Earning Date
  • CRIS 02-25-2025
  • SURG 03-11-2025
  • Dividend Yield
  • CRIS N/A
  • SURG N/A
  • EPS Growth
  • CRIS N/A
  • SURG N/A
  • EPS
  • CRIS N/A
  • SURG N/A
  • Revenue
  • CRIS $10,259,000.00
  • SURG $83,602,653.00
  • Revenue This Year
  • CRIS N/A
  • SURG N/A
  • Revenue Next Year
  • CRIS N/A
  • SURG $59.69
  • P/E Ratio
  • CRIS N/A
  • SURG N/A
  • Revenue Growth
  • CRIS 0.44
  • SURG N/A
  • 52 Week Low
  • CRIS $2.86
  • SURG $1.33
  • 52 Week High
  • CRIS $17.49
  • SURG $8.08
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 43.26
  • SURG 42.29
  • Support Level
  • CRIS $3.10
  • SURG $1.37
  • Resistance Level
  • CRIS $3.55
  • SURG $1.55
  • Average True Range (ATR)
  • CRIS 0.19
  • SURG 0.09
  • MACD
  • CRIS -0.01
  • SURG 0.01
  • Stochastic Oscillator
  • CRIS 21.15
  • SURG 42.86

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.

Share on Social Networks: